483 Response Dolor Technologies Apr 2017

Nicholas Hunt FDA, James Stallings FDA$119.00 - Available Now

FDA investigators audited the Dolor Technologies - Syracuse, UT, United States facility and issued inspectional observation (via FDA 483) on 17 Apr 2017.

Product details

  • Category:
  • Inspection end: 17 Apr 2017
  • Location: Syracuse, United States
  • FEI: 3009141067
Add To Cart